LGND
Ligand Pharmaceuticals Inc
Price:  
79.39 
USD
Volume:  
181,734.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

LGND WACC - Weighted Average Cost of Capital

The WACC of Ligand Pharmaceuticals Inc (LGND) is 8.1%.

The Cost of Equity of Ligand Pharmaceuticals Inc (LGND) is 8.10%.
The Cost of Debt of Ligand Pharmaceuticals Inc (LGND) is 5.50%.

Range Selected
Cost of equity 6.80% - 9.40% 8.10%
Tax rate 20.90% - 41.60% 31.25%
Cost of debt 4.00% - 7.00% 5.50%
WACC 6.8% - 9.4% 8.1%
WACC

LGND WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.63 0.8
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.80% 9.40%
Tax rate 20.90% 41.60%
Debt/Equity ratio 0 0
Cost of debt 4.00% 7.00%
After-tax WACC 6.8% 9.4%
Selected WACC 8.1%